Omega-3 fatty acids protect the brain against Parkinson's disease, according to a new study. Parkinson's disease is caused by the progressive death of the neurons responsible for producing dopamine, a neurotransmitter closely linked with movement control.
More than 50 nutritional experts from an EU committee now recommend pregnant and nursing women supplement their diets on a daily basis with a large amount of DHA, an essential omega-3 fatty acid.
Nutritional supplementation of omega-3-polyunsaturated fatty acids, particularly DHA and EPA, may prevent eye disease, report researchers from Harvard Medical School and the National Eye Institute.
A new meta-analysis by an international team of researchers has determined that folic acid supplementation can effectively reduce the risk of a first stroke by 18 percent.
It is no secret that diabetes is linked with cardiovascular disease: the American Diabetes Association reports more than 65% of people with diabetes die from heart disease or stroke.
Dr. Jane Durga and colleagues from Wageningen University in the Netherlands published findings from a double-blind, placebo controlled study in the January 20th edition of The Lancet medical journal.
A new study in British Medical Journal* reviews the scientific evidence published in previous studies that supports the use of folic acid as a way of reducing the risk of heart disease and strokes.
A new follow-up study to the Framingham Heart Study has determined that DHA (docosahexaenoic acid) significantly decreases the risk of developing all-cause dementia by 47 percent.
A new study conducted by scientists at the Karolinska Institutet in Sweden has found that eating fatty fish, which contains higher levels of DHA* and EPA** (omega-3's) than lean fish, significantly decreases the risk of renal cell carcinoma (RCC) in women.
A comprehensive review of published clinical studies by research associates at Tufts-New England Medical Center has found that increased consumption of DHA* and EPA** (omega-3's), "reduces the rates of all-cause mortality, cardiac and sudden death, and possibly stroke."
A new study by NIH researcher Joseph Hibbeln has found that omega-3 fatty acids taken by pregnant women have a discernible positive effect on the mental and social development of their children.
PBM Pharmaceuticals Inc. announced yesterday that it is conducting a clinical trial of the active supplement Animi-3®, designed to study the related cardiovascular risk reduction.
In Light of the FDA's New "Black Box" Warning for Antidepressants, NewYork-Presbyterian/Weill Cornell Physician-Scientists Call for Further Investigation of Omega-3s
Folic Acid, Vitamin B6 and Vitamin B12 Also May Lower the Risk of Cardiovascular Disease and Dementia by Decreasing the Levels of Homocysteine in the Blood
